REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio de Patologia y Citologia Citosalud S.A.S (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Laboratorio de Patologia y Citologia Citosalud S.A.S Profile Updated: August 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Laboratorio de Patologia y Citologia Citosalud S.A.S is a company based in Colombia, with its head office in Manizales. It operates in the Diagnostic Imaging Centers industry. The company was established on July 15, 2004. Laboratorio de Patologia y Citologia Citosalud S.A.S currently employs 32 (2024) people. The company’s latest financial report indicates a net sales revenue increase of 17.6% in 2023. During that time, Laboratorio de Patologia y Citologia Citosalud S.A.S’s total assets grew by 11.36%. The net profit margin of Laboratorio de Patologia y Citologia Citosalud S.A.S decreased by 0.45% in 2023.

Headquarters
Calle 64 24-27
Manizales; Caldas;

Contact Details: Purchase the Laboratorio de Patologia y Citologia Citosalud S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorio de Patologia y Citologia Citosalud S.A.S report to view the information.
Outstanding Shares:
Purchase the Laboratorio de Patologia y Citologia Citosalud S.A.S report to view the information.
Incorporation Date:
July 15, 2004
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Laboratorio de Patologia y Citologia Citosalud S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
17.6%
Total operating revenue
17.6%
Operating profit (EBIT)
-9.39%
EBITDA
-5.85%
Net Profit (Loss) for the Period
9.86%
Total assets
11.36%
Total equity
-3.73%
Operating Profit Margin (ROS)
-4.23%
Net Profit Margin
-0.45%
Return on Equity (ROE)
1.22%
Quick Ratio
-1.8%
Cash Ratio
-1.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?